Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Gensci Regeneration Sciences Inc. (GNS) -- Ignore unavailable to you. Want to Upgrade?

To: Andras who wrote (183)	7/4/1999 6:50:00 PM
From: Edward W. Richmond	Respond to of 225

Andras, you are quite correct about companies shrinking to become great. Neither can they "buy sales" to become great. We may be successfully taking market share. However, if our growth in market share is the result of selling at less than total cost, we have a disaster in the making. I'm not saying that is the current situation. We will be able to better determine this by Q2, Q3 and Q4 results. Q4 will likely be buried in the annual statement and released in May/June 2000. I think we should be able to evaluate the Sales/Admin costs with the Q2 and Q3 results. You mentioned Osteopharm. You may find it interesting to review the cost and conditions of the Osteopharm purchase. In particular, what did we pay for a product and at what stage in development was it. However, that is a different issue which is really history. I appreciate your comments and I wish you great success with your GNS investment. Of course, my family would also benefit nicely. Best regards, Ed